Sorrento Therapeutics, Inc.

Insider Reports History

Entity
Company
Location
4955 Directors Place, San Diego, CA
Signature
By: /s/ Mohsin Y. Meghji Chief Restructuring Officer of Sorrento Therapeutics, Inc.
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Sorrento Therapeutics, Inc.:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Scilex Holding Co 10%+ Owner Common Stock 1.92M $1.69M $0.88 Sep 21, 2023 Direct
Celularity Inc 10%+ Owner Class A Common Stock 5.05M $1.26M $0.25 Oct 5, 2023 Direct
Scilex Holding Co 10%+ Owner Warrants to Purchase Common Stock 0 $0.35 Sep 21, 2023 Direct

Insider Reports Filed by Sorrento Therapeutics, Inc.

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CELU Celularity Inc Sep 29, 2023 2 $0 4 Oct 5, 2023 10%+ Owner
SCLX Scilex Holding Co Sep 21, 2023 2 $0 4 Sep 25, 2023 10%+ Owner
SCLX Scilex Holding Co Jan 19, 2023 1 $0 4 Jan 23, 2023 10%+ Owner
SCLX Scilex Holding Co Dec 2, 2022 1 $78.9K 4 Dec 2, 2022 10%+ Owner
SCLX Scilex Holding Company/DE Nov 25, 2022 1 $20.2K 4 Nov 25, 2022 10%+ Owner
SCLX Scilex Holding Company/DE Nov 23, 2022 1 $176K 4 Nov 23, 2022 10%+ Owner
SCLX Scilex Holding Company/DE Nov 22, 2022 1 $152K 4 Nov 22, 2022 10%+ Owner
SCLX Vickers Vantage Corp. I Nov 10, 2022 2 $0 4 Nov 15, 2022 10%+ Owner
SCLX Vickers Vantage Corp. I Nov 10, 2022 0 $0 3 Nov 15, 2022 10%+ Owner
CELU Celularity Inc Jul 16, 2021 0 $0 3 Jul 23, 2021 10%+ Owner